Wockhardt gets GMP Compliance Certificate for manufacturing unit in Ankleshwar

23 Aug 2019 Evaluate

Wockhardt has received GMP Compliance Certificate from French National Agency for Medicines and Health Products Safety for its manufacturing Unit at Ankleshwar, Gujarat. The manufacturing facility complies with the principles of Good Manufacturing Practices for active substances.

This is reflected in the Eudra GMDP database. The said GMP Compliance Certificate is valid for a period of 3 years i.e. upto April 2, 2022. EudraGMDP is the name of the European Union database which inter-alia contains Good Manufacturing (GMP) Certificates.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

236.75 4.95 (2.14%)
Aug 12, 18:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 913.40
Cipla 1027.35
Dr. Reddys Lab 4262.25
Lupin 682.60
Zydus Lifesciences 386.90
View more..